- Trials with a EudraCT protocol (3,521)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (105)
3,521 result(s) found for: Bone marrow.
Displaying page 1 of 177.
EudraCT Number: 2009-017924-18 | Sponsor Protocol Number: P10 | Start Date*: 2011-01-04 |
Sponsor Name: | ||
Full Title: Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual refractory angina pectoris and documented ischemia | ||
Medical condition: In coronary artery disease atherosclerosis leads to a decrease in lumen diameter of the large epicardial arteries, causing a deficit in blood flow known as ischemia. This ischemia can cause chest p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004285-18 | Sponsor Protocol Number: 00002 | Start Date*: 2012-11-08 |
Sponsor Name:Helsingin yliopisto | ||
Full Title: The pain relieving effect of nitrous oxide during bone marrow aspiration and biopsy - a placebo-controlled and randomized trial | ||
Medical condition: This study is performed on adult patients with suspected or known hematologic disease undergoing bone marrow aspiration and biopsy. Study investigates inhaled mixture of nitrous oxide and oxygen in... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021811-17 | Sponsor Protocol Number: 00001 | Start Date*: 2010-10-18 |
Sponsor Name:Helsingin yliopisto [...] | ||
Full Title: Suun limakalvolle annosteltu fentanyyli luuydinaspiraatioon ja -biopsiaan liittyvän kivun hoidossa | ||
Medical condition: This study is performed on adult patients with suspected or known hematologic disease undergoing bone marrow aspiration and biopsy. Study investigates oral transmucosal fentanyl in the treatment of... | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004942-15 | Sponsor Protocol Number: CZOL446EIT14 | Start Date*: 2005-12-15 | |||||||||||
Sponsor Name:NOVARTIS FARMA | |||||||||||||
Full Title: A prospective, randomized, multi-center comparative 2-arm trial on efficacy and safety of zoledronic acid every 3-months vs. every 4 weeks beyond approximately 1 year of treatment with zoledronic... | |||||||||||||
Medical condition: bone metastasis in patients with breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003771-19 | Sponsor Protocol Number: 2019-100 | Start Date*: 2019-11-19 | |||||||||||
Sponsor Name:Aarhus Universitetshospital | |||||||||||||
Full Title: The effect of improved insulin sensitivity on bone turnover markers and bone biomechanical properties in persons with type 2 diabetes mellitus | |||||||||||||
Medical condition: Type 2 diabetes mellitus Diabetic bone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018491-24 | Sponsor Protocol Number: 31295 | Start Date*: 2010-07-15 | |||||||||||
Sponsor Name:Vrije Universiteit Medical Center | |||||||||||||
Full Title: Effect of aminobisphosphonates and statins on circulating Vy9Vd2-T cells | |||||||||||||
Medical condition: patients with malignant bone metastases | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-009374-27 | Sponsor Protocol Number: 20080540 | Start Date*: 2009-08-27 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety of Denosumab in the Treatment of Bone Metastases in Subjects with Advanced Cancer or Multiple Myeloma | |||||||||||||
Medical condition: Bone metastases in subjects with advanced cancer or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-006726-34 | Sponsor Protocol Number: Anti TNF- aGvHD | Start Date*: 2009-02-23 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Anti-TNF monoclonal antibody to treat acute GvHD refractary to the first line therapy with steroids | |||||||||||||
Medical condition: Anti-TNF monoclonal antibody to treat acute GvHD refractary to the first line therapy with steroids | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005410-21 | Sponsor Protocol Number: RAE03 | Start Date*: 2006-04-20 |
Sponsor Name:Bradford Teaching Hospitals NHS Foundation Trust | ||
Full Title: Improving the Patient's Experience of a Bone Marrow Biopsy - An evidence based approach to service improvement. | ||
Medical condition: Procedural pain experienced during bone marrow biopsy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002782-37 | Sponsor Protocol Number: ENT05 | Start Date*: 2005-11-17 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: A Randomised Trial of Inhaled Entonox Plus Local Anaesthesia Versus Intravenous Midazolam Plus Local Anaesthesia To Improve Pain Control During Bone Marrow Biopsy | ||
Medical condition: This study will involve a group of patients requiring diagnostic bone marrow aspiration and biopsy. The reasons for these will include haematological abnormalities of the blood count , which may be... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002310-22 | Sponsor Protocol Number: 35/2008/O/Sper | Start Date*: 2008-06-16 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | ||||||||||||||||||
Full Title: A multicenter phase II trial of Recipient pre-treatment with Short-Term Rapamycin for the prevention of acute GVHD after hematopoietic stem cell transplantation in Elderly Patients | ||||||||||||||||||
Medical condition: Graft Versus Host Disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012479-93 | Sponsor Protocol Number: 7302 | Start Date*: 2009-09-09 |
Sponsor Name:Nina Olofsson | ||
Full Title: Multimodal drug infiltration during bone marrow aspiration. A randomized dubble blind controlled study | ||
Medical condition: Procedure pain for bone marrow aspiration, and painscore during 24 hour after aspiration | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006480-23 | Sponsor Protocol Number: 10,176 | Start Date*: 2007-10-12 |
Sponsor Name:University Hospitals of Leicester | ||
Full Title: Autologous Bone Marrow-Derived Cells for Cardioprotection During Heart Surgery | ||
Medical condition: Improvement of cardioprotection during elective coronary artery bypass graft surgery using the patients own bone marrow cells. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001825-28 | Sponsor Protocol Number: T2DM-CLI-2012 | Start Date*: 2012-08-20 |
Sponsor Name:Fakultní nemocnice Ostrava,Czech Republic | ||
Full Title: Randomised clinical study of autologous bone marrow aspirate concentrate (BMAC) activity fo No_option_critical limb ischemia in Type-II diabetes mellitus (DILAEG) | ||
Medical condition: No-option critical limb ischemia patients with T2DM and foot ulcers | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2009-012189-30 | Sponsor Protocol Number: BC1-09 | Start Date*: 2009-10-30 | |||||||||||
Sponsor Name:Algeta ASA | |||||||||||||
Full Title: An open-label Phase IIa, non-randomised, study of Alpharadin in breast cancer patients with bone dominant disease who are no longer considered suitable for endocrine therapy | |||||||||||||
Medical condition: Breast cancer patients with bone dominant disease who have progressed on endocrine therapy and are no longer considered suitable for further endocrine therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-000848-65 | Sponsor Protocol Number: 20050244 | Start Date*: 2006-09-01 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in Subjects with Advanced Cancer (Excluding Breast and Prostate... | |||||||||||||
Medical condition: Treatment of bone metastases in subjects with advanced cancer (excluding breast and prostate cancer) or multiple myeloma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) PT (Completed) AT (Completed) NL (Completed) BE (Completed) HU (Completed) GB (Completed) LT (Completed) DE (Completed) SK (Completed) LV (Completed) SE (Completed) IT (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003072-31 | Sponsor Protocol Number: 2378 | Start Date*: 2018-05-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: The effects of sex hormone administration on marrow and visceral adiposity | ||
Medical condition: Healthy transgender persons (the effect of differences in sex hormones on the amount of bone marrow fat) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019415-38 | Sponsor Protocol Number: CZOL446HDE38T | Start Date*: 2011-03-23 | |||||||||||
Sponsor Name:Universitätsklinikum Würzburg | |||||||||||||
Full Title: A prospective, bicentric, randomised, primarily double blind, placebo-controlled study to evaluate the efficacy of zoledronic acid for the treatment of bone marrow syndrome | |||||||||||||
Medical condition: Determination of efficacy of Zoledronic Acid on the treatment of bone marrow edema syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005327-41 | Sponsor Protocol Number: INT0211 | Start Date*: 2012-04-05 | |||||||||||
Sponsor Name:ISTITUTO NAZIONALE PER LA CURA TUMORI | |||||||||||||
Full Title: Clinical trial randomized and controlled to compare the analgesic efficacy of the association zoledronic acid and 153Sm-lexidronam vs zoledronic acid in patients with skeletal metastases from hormo... | |||||||||||||
Medical condition: Population enrolled in the study is represented by patients bearing advanced prostatic cancer with skeletal metastases and bone pain cancer-associated and treated with analgesic drugs | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001845-34 | Sponsor Protocol Number: AMBIHOW | Start Date*: 2011-09-15 | |||||||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||||||||||||
Full Title: LIPOSOMAL AMPHOTERICIN B (AMBISOME) 10 mg/kg once a week for 10 weeks as maintenance antifungal therapy for Proven/Probable Invasive Fungal Infection in hematologic patients with Acute Myeloid Leuk... | |||||||||||||||||||||||
Medical condition: Proven/Probable Invasive Fungal Infection in hematologic patients with Acute Myeloid Leukaemia and/or in Allogeneic Hematopoietic Stem Cell Transplant recipients. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
